143
Views
5
CrossRef citations to date
0
Altmetric
Research Article

The management of skin toxicity during erlotinib in advanced non-small cell lung cancer: how much does it cost?

&
Pages 248-251 | Received 19 Nov 2012, Accepted 19 Dec 2012, Published online: 01 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francisco Batel Marques, Ana Penedones, Diogo Mendes & Carlos Alves. (2016) A systematic review of observational studies evaluating costs of adverse drug reactions. ClinicoEconomics and Outcomes Research 8, pages 413-426.
Read now

Articles from other publishers (4)

D. A. Andreev, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, K. I. Polyakova, V. A. Dubovtseva & T. E. Maksimova. (2020) Photodynamic therapy as an up-to-date medical technology for the treatment of vulgar acne. Vestnik dermatologii i venerologii 95:6, pages 44-54.
Crossref
Lei Chen, Jacqueline Brown, Dale Quentin Marmaduke, Carlos Mayo, Gerrit Grau, Yiu-Keung Lau & Coleman K Obasaju. (2018) Rash management and treatment persistence of cancer patients treated with epidermal growth factor receptor inhibitors in the Truven MarketScan® research database. Supportive Care in Cancer 26:7, pages 2369-2377.
Crossref
Yu Li, Jasmit S. Minhas & Kimberly G. Blumenthal. 2018. Drug Allergy Testing. Drug Allergy Testing 11 18 .
Jacopo Giuliani & Andrea Bonetti. (2016) The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors. Clinical Lung Cancer 17:6, pages 471-473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.